Reactions to Being “Powered By Purpose” on Clinical Trials Day 2025

Original interview with ARCP for Clinical Trials Day 2025 available here. Author: Mathilde Tournay

My clinical research power is…

…bridging the gap between statistical rigor and clinical development. As a biostatistician, I bring deep expertise in data and complex statistical methods together with a solid understanding of science and medicine to ensure that clinical evidence is not just methodologically sound but also meaningful. My goal is to transform data into actionable insights that truly support better decisions for patients and clinicians alike.

The greatest challenge I see to clinical research right now is…

…designing trials that can manage growing complexity while staying focused on patient needs. As trials evolve to include more data, endpoints, and subgroups, it becomes harder to reflect the diverse preferences of the people they’re meant to serve. Too often, key outcomes are chosen without patient input, leading to evidence that misses the mark on real-life impact.

The greatest opportunity I see for clinical research in the near future is…

 …embedding patient preferences very early into the design of trials—starting with how outcomes are selected and prioritized. Tools that enable this shift will drive more meaningful evidence generation, reduce trial inefficiencies, and accelerate the delivery of treatments that patients truly value. We must do better at integrating patient priorities from the outset and making full use of the data we collect to ensure research reflects what matters most to those living with the condition.